Ingalls & Snyder LLC’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-13,185
Closed -$189K 408
2020
Q1
$189K Sell
13,185
-14,669
-53% -$210K 0.01% 359
2019
Q4
$758K Sell
27,854
-18,075
-39% -$492K 0.04% 219
2019
Q3
$1.32M Sell
45,929
-3,814
-8% -$109K 0.06% 184
2019
Q2
$1.38M Sell
49,743
-3
-0% -$83 0.07% 187
2019
Q1
$1.65M Buy
49,746
+220
+0.4% +$7.31K 0.08% 173
2018
Q4
$1.44M Buy
49,526
+605
+1% +$17.6K 0.08% 173
2018
Q3
$2.25M Sell
48,921
-125
-0.3% -$5.75K 0.09% 155
2018
Q2
$1.83M Sell
49,046
-53
-0.1% -$1.98K 0.09% 154
2018
Q1
$1.45M Hold
49,099
0.07% 171
2017
Q4
$1.69M Sell
49,099
-4,500
-8% -$155K 0.08% 165
2017
Q3
$1.94M Buy
53,599
+350
+0.7% +$12.7K 0.1% 136
2017
Q2
$1.38M Sell
53,249
-975
-2% -$25.2K 0.07% 161
2017
Q1
$1.04M Sell
54,224
-5,860
-10% -$113K 0.06% 191
2016
Q4
$1M Sell
60,084
-44,987
-43% -$750K 0.05% 189
2016
Q3
$2.16M Sell
105,071
-31,941
-23% -$657K 0.12% 128
2016
Q2
$4.19M Buy
137,012
+777
+0.6% +$23.8K 0.25% 78
2016
Q1
$5.1M Sell
136,235
-5,151
-4% -$193K 0.32% 60
2015
Q4
$6.1M Sell
141,386
-3,110
-2% -$134K 0.39% 56
2015
Q3
$5.42M Buy
144,496
+6,936
+5% +$260K 0.35% 59
2015
Q2
$4.68M Sell
137,560
-6,208
-4% -$211K 0.26% 74
2015
Q1
$5.09M Buy
143,768
+2,724
+2% +$96.4K 0.28% 69
2014
Q4
$4.8M Sell
141,044
-655
-0.5% -$22.3K 0.28% 70
2014
Q3
$5.47M Buy
141,699
+1,394
+1% +$53.8K 0.29% 67
2014
Q2
$5.46M Buy
140,305
+4,113
+3% +$160K 0.27% 72
2014
Q1
$4.66M Sell
136,192
-8,112
-6% -$277K 0.25% 76
2013
Q4
$3.03M Sell
144,304
-18,231
-11% -$382K 0.17% 98
2013
Q3
$3.82M Buy
162,535
+24,126
+17% +$567K 0.23% 79
2013
Q2
$3.72M Buy
+138,409
New +$3.72M 0.24% 77